Regeneron Pharmaceuticals REGN Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.5B+2.1% | $4.41B+11.6% | $3.95B-8.9% | $4.34B-46.3% | ||
| $543.7M+12.6% | $482.9M+14.7% | $421M+23.3% | $341.4M+19.3% | ||
| $993.7M+1.1% | $982.8M+11.1% | $885M+22.1% | $725M+20.5% | ||
| $4.98B+12.6% | $4.42B-3.8% | $4.59B-8.4% | $5.01B-29.2% | ||
| $898.4M+18.9% | $755.9M+5.2% | $718.6M+21.8% | $590.1M+6.9% | ||
| —— | —— | -$3.19B+19.9% | -$3.98B+27.8% | ||
| $370.3M— | $0— | $0— | —— | ||
| $3.44B+32.1% | $2.6B+16.5% | $2.24B+7.3% | $2.08B+26.6% | ||
| -$3.72B-68.8% | -$2.2B-22.9% | -$1.79B-77.4% | -$1.01B— | ||
| $634.7M— | —— | —— | —— | ||
| $4.08B+11.3% | $3.66B-5.4% | $3.88B-12.4% | $4.42B-32.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Regeneron Pharmaceuticals generate?
- Regeneron Pharmaceuticals (REGN) generated $5.0B in operating cash flow over the trailing twelve months.
- What is Regeneron Pharmaceuticals's free cash flow?
- After $899.7M of capital expenditures, Regeneron Pharmaceuticals's free cash flow was $4.1B over the trailing twelve months, up 32.6% year over year.
- Where does Regeneron Pharmaceuticals's cash flow data come from?
- Every line is extracted from Regeneron Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
